The Patent Finder

Staten Biotechnology B.V.

Also on record
Records under this name other than patents Staten Biotechnology B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Staten Biotechnology B.V.

PatentTitleStatus Expires Confidence
US 11,248,041Anti-ApoC3 antibodies
Lapsed on the fee record
Ended Feb 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2026From the USPTO record
US 11,248,042Polynucleotides encoding anti-ApoC3 antibodies
Lapsed on the fee record
Ended Feb 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2026From the USPTO record
US 11,242,381Anti-ApoC3 antibodies and methods of use thereof
Lapsed on the fee record
Ended Feb 8, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 8, 2026From the USPTO record
US 11,091,539Anti-ApoC3 antibodies and methods of use thereof
Lapsed on the fee record
Ended Aug 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 17, 2025From the USPTO record
US 10,538,583Anti-APOC3 antibodies and compositions thereof
Lapsed on the fee record
Ended Jan 21, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 21, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited